AbCellera Biologics Inc.ABCLNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-54.6%/yr
Long-term compound
Percentile
P78
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 84.21% |
| Q3 2025 | -58.33% |
| Q2 2025 | 20.00% |
| Q1 2025 | -25.00% |
| Q4 2024 | 29.41% |
| Q3 2024 | -30.77% |
| Q2 2024 | 7.14% |
| Q1 2024 | 12.50% |
| Q4 2023 | -60.00% |
| Q3 2023 | 9.09% |
| Q2 2023 | 21.43% |
| Q1 2023 | -40.00% |
| Q4 2022 | -211.11% |
| Q3 2022 | 550.00% |
| Q2 2022 | -103.39% |
| Q1 2022 | 180.95% |
| Q4 2021 | 362.50% |
| Q3 2021 | -700.00% |
| Q2 2021 | -102.33% |
| Q1 2021 | 0.00% |
| Q4 2020 | 4357.43% |
| Q3 2020 | -132.48% |
| Q2 2020 | 420.62% |
| Q1 2020 | -27.63% |
| Q4 2019 | -3900.00% |
| Q3 2019 | 110.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |